Deutsche Bank’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,016
| Closed | -$115K | – | 4218 |
|
|
2022
Q1 | $115K | Sell |
1,016
-120
| -11% | -$13.9K | ﹤0.01% | 3532 |
|
|
2021
Q4 | $109K | Buy |
1,136
+59
| +5% | +$5.31K | ﹤0.01% | 3669 |
|
|
2021
Q3 | $95K | Buy |
1,077
+156
| +17% | +$15.4K | ﹤0.01% | 3919 |
|
|
2021
Q2 | $113K | Buy |
921
+564
| +158% | +$78K | ﹤0.01% | 4087 |
|
|
2021
Q1 | $57K | Sell |
357
-34
| -9% | -$5.77K | ﹤0.01% | 4198 |
|
|
2020
Q4 | $60K | Buy |
391
+112
| +40% | +$20.1K | ﹤0.01% | 4067 |
|
|
2020
Q3 | $52K | Buy |
279
+121
| +77% | +$19.8K | ﹤0.01% | 3874 |
|
|
2020
Q2 | $19K | Buy |
+158
| New | +$16.1K | ﹤0.01% | 4052 |
|
|
2020
Q1 | – | Sell |
-40
| Closed | -$3K | – | 4547 |
|
|
2019
Q4 | $3K | Buy |
+40
| New | +$3.33K | ﹤0.01% | 4752 |
|
|
2019
Q3 | – | Sell |
-19
| Closed | -$2K | – | 5076 |
|
|
2019
Q2 | $2K | Sell |
19
-75
| -80% | -$9.85K | ﹤0.01% | 5177 |
|
|
2019
Q1 | $6K | Sell |
94
-5
| -5% | -$439 | ﹤0.01% | 4999 |
|
|
2018
Q4 | $6K | Sell |
99
-276
| -74% | -$32.3K | ﹤0.01% | 4950 |
|
|
2018
Q3 | $41K | Buy |
375
+200
| +114% | +$522K | ﹤0.01% | 4769 |
|
|
2018
Q2 | $481K | Buy |
175
+162
| +1,246% | +$374K | ﹤0.01% | 3865 |
|
|
2018
Q1 | $35K | Buy |
13
+12
| +1,200% | +$27.5K | ﹤0.01% | 4863 |
|
|
2017
Q4 | $3K | Buy |
+1
| New | +$2.21K | ﹤0.01% | 4893 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4967 |
|
|
2017
Q2 | – | Sell |
-14
| Closed | -$18.7K | – | 5014 |
|
|
2017
Q1 | $22K | Sell |
14
-19
| -58% | -$34.8K | ﹤0.01% | 4478 |
|
|
2016
Q4 | $55K | Buy |
33
+23
| +230% | +$50.4K | ﹤0.01% | 4327 |
|
|
2016
Q3 | $23K | Sell |
10
-8
| -44% | -$19.7K | ﹤0.01% | 4492 |
|
|
2016
Q2 | $45K | Buy |
18
+5
| +38% | +$16.4K | ﹤0.01% | 4455 |
|
|
2016
Q1 | $47K | Hold |
13
| – | – | ﹤0.01% | 4338 |
|
|
2015
Q4 | $60K | Sell |
13
-14
| -52% | -$45.7K | ﹤0.01% | 4313 |
|
|
2015
Q3 | $42K | Sell |
27
-258
| -91% | -$1.29M | ﹤0.01% | 4530 |
|
|
2015
Q2 | $2.41M | Buy |
285
+37
| +15% | +$353K | ﹤0.01% | 2309 |
|
|
2015
Q1 | $2.48M | Sell |
248
-8
| -3% | -$73.5K | ﹤0.01% | 2284 |
|
|
2014
Q4 | $2.55M | Buy |
+256
| New | +$1.97M | ﹤0.01% | 2482 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 5757 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 5949 |
|
Other funds holding IMUX
RI
OFM
CAC
LCM
CC
AG
Deutsche Bank's IMUX Position: Q2 2022 in Review
Deutsche Bank sold out of Immunic (IMUX) in Q2 2022, closing a stake of 1,016 shares — an estimated $115K sold.
Deutsche Bank first reported a position in IMUX in Q4 2014 and held it in 26 quarters. The position peaked at $2.55M in Q4 2014. 72 funds tracked by Wall St. Rank hold IMUX as of Q2 2022.
- Deutsche Bank reported no remaining Immunic position as of Q2 2022 after selling out during the quarter.
- Deutsche Bank sold 1,016 Immunic shares in Q2 2022, an estimated $115K.
- Deutsche Bank first reported a position in Immunic in Q4 2014 and held it in 26 quarters.
- Deutsche Bank's Immunic position peaked at $2.55M in Q4 2014.
- 72 funds tracked by Wall St. Rank held Immunic as of Q2 2022.
Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.